Related Experiment Video
Updated: Jun 3, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
Transforming growth factor α levels in pancreatic fluid
Courtney J Doyle1, Narasimhan P Agaram, Michele T Yip-Schneider
1Departments of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Insights
Transforming growth factor alpha (TGF-α) in pancreatic fluid may help diagnose intraductal papillary mucinous neoplasm (IPMN). Levels above 95 pg/mL show promise for IPMN diagnosis, though further validation is needed.
Area of Science:
- Gastroenterology
- Oncology
- Biochemistry
Background:
- Intraductal papillary mucinous neoplasm (IPMN) is a premalignant pancreatic lesion.
- Accurate diagnosis of IPMN versus other pancreatic cystic lesions is crucial for patient management.
- Biomarkers in pancreatic fluid are being investigated for diagnostic utility.
Purpose of the Study:
- To evaluate the diagnostic potential of transforming growth factor alpha (TGF-α) levels in pancreatic fluid (PF) for distinguishing IPMN from other pancreatic cystic lesions.
- To correlate PF-TGF-α levels with pathological findings and grades of dysplasia in IPMN.
Main Methods:
- Prospective collection of pancreatic fluid samples during endoscopy or operation.
- Analysis of PF-TGF-α levels using enzyme-linked immunosorbent assay (ELISA).
- Immunohistochemical analysis of TGF-α in IPMN tissues.
Main Results:
- No significant difference in mean PF-TGF-α levels was observed between IPMN and other pancreatic lesions (serous cystadenoma, mucinous cystic neoplasm, pseudocysts, pancreatic ductal adenocarcinoma, sphincter of Oddi dysfunction).
- PF-TGF-α levels exceeding 95 pg/mL were uniquely observed in IPMN cases among all diagnoses studied.
- A correlation was found between ELISA-measured PF-TGF-α levels and immunohistochemistry results in low-grade IPMN specimens.
Conclusions:
- Mean PF-TGF-α levels alone are not sufficient to differentiate IPMN from other pancreatic cystic lesions or conditions.
- A PF-TGF-α threshold of 95 pg/mL may serve as a potential biomarker for IPMN diagnosis.
- Prospective studies are required to validate the diagnostic utility of elevated PF-TGF-α levels for IPMN.
Unlabelled:
To determine if the level of transforming growth factor α (TGF-α) in the pancreatic fluid (PF) can diagnose intraductal papillary mucinous neoplasm (IPMN) versus other cystic lesions of the pancreas in patients.
Methods:
Pancreatic fluid was prospectively obtained from patients during routine endoscopy and/or operation at Indiana University Hospital. Pancreatic fluid TGF-α levels were analyzed by enzyme-linked immunosorbent assay. Intraductal papillary mucinous neoplasm tissue was also analyzed by TGF-α immunohistochemistry.
Results:
Sixty-nine fluid samples from 58 patients with the following pathologically confirmed pancreatic disorders were analyzed: IPMN (26 patients), serous cystadenoma (6), mucinous cystic neoplasm (9), pseudocysts (5), non-IPMNY associated pancreatic ductal adenocarcinoma (6), and sphincter of Oddi dysfunction (6). There was no significant difference between the mean PF-TGF-α levels in each category or between different dysplastic grades of IPMN. However, of all the diagnoses examined, only IPMN demonstrated PF-TGF-α levels greater than 95 pg/mL. In low-grade IPMN specimens, TGF-α immunohistochemistry correlated with enzyme-linked immunosorbent assay levels.
Conclusions:
The mean PF-TGF-α levels are not significantly different in IPMN lesions compared with those in other cystic pancreatic lesions, pancreatic ductal adenocarcinoma, or sphincter of Oddi dysfunction. However, PF-TGF-α levels more than 95 pg/mL may be useful in diagnosing IPMN. This assertion requires prospective validation.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...

